Asad Ikram: Headache and Visual Impairment in Idiopathic Intracranial Hypertension
Asad Ikram, Assistant Professor of Medicine at Anne Burnett Marion School of Medicine at Texas Christian University, shared a post on LinkedIn about a recent article by Gabriel Bsteh et al, published on European Journal of Neurology, adding:
“Headache and Visual Impairment in idiopathic intracranial hypertension (IIH)
The role of surgical interventions in IIH related headache vs visual impairment and what those offer: a very pragmatic look at when and in whom procedures actually help.
Across multiple tertiary centers, investigators evaluated outcomes of patients undergoing CSF shunting, venous sinus stenting, or optic nerve sheath fenestration (ONSF), with a focus on how indication for surgery (vision vs headache) influences results.
What stands out is that surgery is consistently effective for vision preservation, with most patients showing stabilization or improvement in visual function after intervention.
However, outcomes for headache control were far less predictable, with a significant proportion continuing to have persistent or recurrent symptoms despite technically successful procedures.
Complication and revision rates particularly for shunts were not negligible, reinforcing the need for careful patient selection.
From a neurovascular and stroke-adjacent perspective, this is highly relevant because we often encounter IIH in young patients presenting with headache or visual symptoms, sometimes mimicking vascular pathology and often associated with Dural Venous Sinus thrombosis needing anticoagulation.
The key takeaway is that surgical intervention should be driven primarily by visual risk rather than headache alone, and that multidisciplinary evaluation (neurology, neuro-ophthalmology, neurosurgery) is critical before committing patients to invasive therapies.”
Title: Surgical Interventions in Idiopathic Intracranial Hypertension—A Comprehensive Multi‐Center Study of Outcome and the Role of Treatment Indication
Authors: Gabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, Steffen Hamann, Johanne Juhl Korsbæk, Nik Krajnc, Stefan Macher, Laleh Dehghani Molander, Klaus Novak, Therese Wallentin Steenfos, Marianne Wegener, Berthold Pemp, Rigmor Højland Jensen, Dagmar Beier, Kaare Fugleholm, Marianne Juhler, Karl Kirchner, Martin Michl, Christoph Mitsch, Nina Müller, Petersen Bibi Gronemann, Andreas Reitner, Christoph Stapf, Christian Wöber, Karin Zebenholzer
Read the Full Article on European Journal of Neurology
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia